Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of NESP (Novel Erythropoiesis Stimulating Protein) During Concurrent Chemo-Radiation for the Treatment of Cervical Carcinoma.

NCT00039884 is registered in ClinicalTrials.gov with Mirhashemi, Ramin, M.D. as lead sponsor.

NCT NCT00039884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00039884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of NESP (Novel Erythropoiesis Stimulating Protein) During Concurrent Chemo-Radiation for the Treatment of Cervical Carcinoma.
Lead sponsor
Mirhashemi, Ramin, M.D.
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2001
Completion date
March 31, 2003
Enrollment
64
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, cervix neoplasms